ClinTrialApp, a company that provides mobile technologies to accelerate clinical trials and Debiopharm International, part of Debiopharm Group, a Switzerland-based biopharmaceutical company, announced the deployment of ClinTrialApp mobile technology to support its ovarian cancer clinical trial of Debio 1143.

"We are pleased to announce our use of ClinTrialApp (ClinOne) to provide greater support to our clinical research sites"

The collaboration further validates ClinTrialApps (ClinOne) approach for real-time clinical trial content to be delivered to research centers through a mobile application and a web application. "We are pleased to announce our use of ClinTrialApp (ClinOne) - a technology that allows us to provide greater support to our clinical research sites. Clinical research sites are an important element of our clinical development strategy and we would like to lead the way with technology tools that enable them to perform to their full potential", said Mr. Sebastien Del Rizzo, clinical trial manager at Debiopharm International.

"We are delighted to collaborate with Debiopharm International and most importantly we are pleased to be providing a mobile technology solution to their research sites which enables them to access clinical trial content at the point-of-care", according to ClinTrialApp (ClinOne) chief executive officer, Rob Bohacs. ClinTrialApp (ClinOne) provides a global mobile platform for research sites to stay connected and access the right study content in a mobile environment. The company manages nearly 2,000 active clinical trials across 34 countries through its technology.